CC BY-NC-ND 4.0 · Indian J Plast Surg 2021; 54(04): 416-421
DOI: 10.1055/s-0041-1739256
Review Article

Overview and Algorithmic Approach to Management of Male and Female Pattern Hair Loss

Mayank Singh
1   Radiance Cosmedic Centre, New Delhi, India
,
Aparna Acharya
2   Hair Plus, Pune, Maharashtra, India
› Author Affiliations

Abstract

Male and female pattern hair loss (PHL) is an innocuous condition, but it has a major psychological impact on the sufferer. This paper aims to provide a simple algorithmic approach toward diagnosis, staging, and treatment of PHL in males and females. It also aims at simplifying the decision-making process for the surgeon with regard to timing and extent of procedure for hair transplant surgeries. Various treatment options, their merits and demerits, along with scientific evidence supporting or not supporting the treatment options are discussed in detail.



Publication History

Article published online:
14 December 2021

© 2021. Association of Plastic Surgeons of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol 2013; 79 (05) 613-625
  • 2 Medical WG, Ethics P. Spotlight on medical ethics. Hair Transplant Forum Int 2020; 30 (06) 230-231
  • 3 Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 2001; 144 (02) 297-304
  • 4 Blumeyer A, Tosti A, Messenger A. et al; European Dermatology Forum (EDF). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 2011; 9 (Suppl. 06) S1-S57
  • 5 Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther 2019; 13: 2777-2786
  • 6 Goren A, Shapiro J, Roberts J. et al. Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther (Heidelb) 2015; 28 (01) 13-16
  • 7 Mysore V. Finasteride and sexual side effects. Indian Dermatol Online J 2012; 3 (01) 62-65
  • 8 Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol 2021; 84 (03) 737-746
  • 9 Rajput RJ. Controversy: is there a role for adjuvants in the management of male pattern hair loss?. J Cutan Aesthet Surg 2010; 3 (02) 82-86
  • 10 Beer C, Wood S, Veghte RH. A clinical trial to investigate the effect of Cynatine HNS on hair and nail parameters. ScientificWorldJournal 2014; 2014: 641723
  • 11 Ashique S, Sandhu NK, Haque SN, Koley K. A systemic review on topical marketed formulations, natural products, and oral supplements to prevent androgenic alopecia: a review. Nat Prod Bioprospect 2020; 10 (06) 345-365
  • 12 Dhariwala MY, Ravikumar P. An overview of herbal alternatives in androgenetic alopecia. J Cosmet Dermatol 2019; 18 (04) 966-975
  • 13 Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drugs Dermatol 2018; 17 (04) 457-463
  • 14 Giordano S, Romeo M, Lankinen P. Platelet-rich plasma for androgenetic alopecia: Does it work? Evidence from meta analysis. J Cosmet Dermatol 2017; 16 (03) 374-381
  • 15 Egger A, Resnik SR, Aickara D. et al. Examining the safety and efficacy of low-level laser therapy for male and female pattern hair loss: a review of the literature. Skin Appendage Disord 2020; 6 (05) 259-267
  • 16 Chen L, Zhang J, Wang L, Wang H, Chen B. The efficacy and safety of finasteride combined with topical minoxidil for androgenetic alopecia: a systematic review and meta-analysis. Aesthetic Plast Surg 2020; 44 (03) 962-970
  • 17 Gupta AK, Cole J, Deutsch DP. et al. Platelet-rich plasma as a treatment for androgenetic alopecia. Dermatol Surg 2019; 45 (10) 1262-1273
  • 18 Suchonwanit P, Iamsumang W, Rojhirunsakool S. Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study. Am J Clin Dermatol 2019; 20 (01) 147-153
  • 19 Zhou Y, Chen C, Qu Q. et al. The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis. Dermatol Ther (Heidelb) 2020; 33 (04) e13741
  • 20 Kelly Y, Blanco A, Tosti A. Androgenetic alopecia: an update of treatment options. Drugs 2016; 76 (14) 1349-1364
  • 21 Hu R, Xu F, Sheng Y. et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther (Heidelb) 2015; 28 (05) 303-308
  • 22 Tanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai 2012; 95 (10) 1312-1316
  • 23 Khandpur S, Suman M, Reddy BS. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol 2002; 29 (08) 489-498
  • 24 Bernstein RM, Rassman WR. The aesthetics of follicular transplantation. Dermatol Surg 1997; 23 (09) 785-799
  • 25 Bernstein RM, Rassman WR. The logic of follicular unit transplantation. Dermatol Clin 1999; 17 (02) 277-295 , viii, discussion 296
  • 26 Venkataram A, Mysore V. Logic of hair transplantation. J Cutan Aesthet Surg 2018; 11 (04) 169-172